Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,574 Jan 1 – Oct 24, 2026
- Disclosed funding
- $297.3B 3609 disclosed amounts
- Median round
- $14.7M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| V Provides intelligent software platforms for oncology care | $43M | Undisclosed | Healthtech | United States | Investors | |
| ZI Zepo IntelligenceCompany profile Zepo Intelligence develops workspace security software combining human-risk management and threat monitoring. Zepo Intelligence develops workspace security software combining human-risk management and threat monitoring. | $15M | Seed | Cybersecurity | United States | Investors | |
| MT Mirador TherapeuticsCompany profile Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250M | Series B | Biotech | United States | Investors | |
| A AI4EyesCompany profile AI4Eyes develops AI-assisted imaging and software to help eye-care professionals assess ocular conditions and plan care. AI4Eyes develops AI-assisted imaging and software to help eye-care professionals assess ocular conditions and plan care. | CA$3.7M | Undisclosed | AI | Canada | Investors Undisclosed | |
| AA Allos AICompany profile Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies. Causal AI and pharmaceutical development services for reformulating complex drugs and directing laboratory studies. | $5M | Seed | AI | United States | Investors | |
| TB Trailhead BiosystemsCompany profile Develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine Develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine | $20M | Growth | Biotech | United States | Investors | |
| CA Cast AICompany profile Provides automation platform for operating cloud-native and AI workloads at scale Provides automation platform for operating cloud-native and AI workloads at scale | Undisclosed | StrategicUndisclosed | Developer tools | United States | Investors | |
| A AccelsiusCompany profile Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. Two-phase liquid cooling for data centres running dense AI and high-performance computing workloads. | $65M | Series B | Hardware | United States | Investors | |
| OT Oricell TherapeuticsCompany profile Develops next-generation cell therapies for oncology and immunology Develops next-generation cell therapies for oncology and immunology | $70M | Series C1Series C+ | Biotech | China | Investors | |
| F AI-driven study app for university students | €1M | Pre-SeedPre-seed | Edtech | Estonia | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Tractian, Blacksmith, Greptile
158rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
111rounds21led - 3General Catalyst
Tractian, Legora, Different
100rounds12led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds8led - 5Sequoia Capital
Warhound, Whop, Blacksmith
71rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →